AstraZeneca PLC (NASDAQ:AZN)
| 61.22 Delayed Data As of Oct 21 |  +0.59 / +0.97%Today’s Change | 46.48 Today|||52-Week Range 61.34 | +22.46% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 60.63 |
| Today’s open | 60.51 |
| Day’s range | 60.49 - 61.25 |
| Volume | 2,597,746 |
| Average volume (3 months) | 8,852,824 |
| Market cap | $186.6B |
Data as of 4:00pm ET, 10/21/2021
Growth & Valuation
| Earnings growth (last year) | +137.38% |
| Earnings growth (this year) | +37.52% |
| Earnings growth (next 5 years) | +19.80% |
| Revenue growth (last year) | +13.16% |
| P/E ratio | 42.7 |
| Price/Sales | 4.76 |
| Price/Book | 10.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.01 | +0.01% |
| ABBVAbbVie | -0.02 | -0.02% |
| NVONovo Nordisk | -0.14 | -0.13% |
| MRKMerck | -0.27 | -0.33% |
Data as of 5:26pm ET, 10/21/2021
Financials
| Next reporting date | November 12, 2021 |
| EPS forecast (this quarter) | $0.63 |
| Annual revenue (last year) | $27.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
